Hey Gaz, Hope your well, havent seen a post from you for a while. Just looked at the other presentations I see that are all up for viewing https://alteritytherapeutics.com/the-science/ Loved the MRI-AI presentation, really impressive results for early diagnosis of MSA, plus monitoring brain atrophy which would be great, as theyve seen a 16% reduction in brain atrophy with ATH434. I did see the post your mentioned above on the primary release, I posed a Q to Alterity about the differences, although to me what I thought was new was a statement in the conclusion as to why they likely worked differently due to 75mg having more MSA P pts, likely also more advanced to others as well. Over all, all presentations just keep ticking more and more goals. Not long now, FDA will love it, bring on AA and partnership talks.
ATH Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)